The significance of ultra-low EGFR T790M mutations on EGFR-TKI efficacy in patients with NSCLC -the WJOG13119L study

被引：0

作者：

Masuda, Takeshi ^{[1
]}

Miura, Satoru ^{[2
]}

Koso, Hidenori ^{[3
]}

Yanagihara, Kazuhiro ^{[4
]}

Okamoto, Tatsuro ^{[5
]}

Shoda, Hiroyasu ^{[6
]}

Shimizu, Junichi ^{[7
]}

Kanaji, Nobuhiro ^{[8
]}

Hara, Satoshi ^{[9
]}

Sakata, Shinya ^{[10
]}

Tokito, Takaaki ^{[11
]}

Kashiwabara, Kosuke ^{[12
]}

Nishikawa, Kazuo ^{[13
]}

Watanabe, Hiroshi ^{[14
]}

Maeno, Ken ^{[15
]}

Suzuki, Shigeki ^{[16
]}

Hayakawa, Daisuke ^{[17
]}

Yamamoto, Nobuyuki ^{[18
]}

Nakagawa, Kazuhiko ^{[19
]}

Noboru, Hattori ^{[1
]}

机构：

[1] Hiroshima Univ Hosp, Dept Resp Med, Hiroshima, Japan

[2] Niigata Canc Ctr Hosp, Dept Internal Med, Niigata, Japan

[3] Natl Hosp Org, Oita Med Ctr, Dept Surg, Oita, Japan

[4] Kansai Elect Power Hosp, Dept Med Oncol, Osaka, Japan

[5] Natl Hosp Org Kyushu Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan

[6] Hiroshima City Hiroshima Citizens Hosp, Dept Resp Med, Hiroshima, Japan

[7] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi, Japan

[8] Kagawa Univ, Dept Internal Med, Div Hematol Rheumatol & Resp Med, Fac Med, Takamatsu, Kagawa, Japan

[9] Itami City Hosp, Dept Resp Med, Itami, Hyogo, Japan

[10] Kumamoto Univ Hosp, Dept Resp Med, Kumamoto, Japan

[11] Kurume Univ, Div Respirol Neurol & Rheumatol, Dept Internal Med, Sch Med, Kurume, Fukuoka, Japan

[12] Kumamoto Reg Med Ctr, Dept Resp Med, Kumamoto, Japan

[13] Oita Univ, Fac Med, Dept Med Oncol & Hematol, Oita, Japan

[14] Saka Gen Hosp, Dept Resp Med, Shiogama, Japan

[15] Nagoya City Univ, Dept Resp Med Allergy & Clin Immunol, Grad Sch Med Sci, Nagoya, Aichi, Japan

[16] Sagamihara Kyodo Hosp, Dept Gen Thorac Surg, Sagamihara, Kanagawa, Japan

[17] Juntendo Univ, Fac Med, Dept Resp Med, Tokyo, Japan

[18] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan

[19] Kindai Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka, Japan

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷

关键词：

D O I：

10.1016/j.annonc.2022.05.028

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O6-3

引用

页码：S470 / S471

页数：2

共 50 条

[41] Detection of EGFR Mutations T790M and L858R for Therapeutic Guidance of NSCLC
Rana, M.
Asil, S. M.
Boutin, C.
Kachwala, M. J.
Espejo, J.
Argun, A. A.
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S496 - S496
[42] Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients
Matsuo, Norikazu
Azuma, Koichi
Sakai, Kazuko
Hattori, Satoshi
Kawahara, Akihiko
Ishii, Hidenobu
Tokito, Takaaki
Kinoshita, Takashi
Yamada, Kazuhiko
Nishio, Kazuto
Hoshino, Tomoaki
SCIENTIFIC REPORTS, 2016, 6
[43] Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients
Norikazu Matsuo
Koichi Azuma
Kazuko Sakai
Satoshi Hattori
Akihiko Kawahara
Hidenobu Ishii
Takaaki Tokito
Takashi Kinoshita
Kazuhiko Yamada
Kazuto Nishio
Tomoaki Hoshino
Scientific Reports, 6
[44] ASTRIS real world study of osimertinib in patients (pts) with EGFR T790M NSCLC: Efficacy analysis by tissue or plasma T790M test
Freitas, H. C.
Park, K.
Kim, D-W.
Tiseo, M.
Hochmair, M. J.
Chang, G-C.
Shi, Y-K.
Moran, T.
Chen, Y.
Laskin, J.
Solomon, B.
Miranda, M.
Rigas, J.
Cheema, P. K.
Kim, S-W.
ANNALS OF ONCOLOGY, 2018, 29 : 149 - 149
[45] TAS3351 is a 4th-generation EGFR-TKI overcoming T790M and C797S-mediated resistance in NSCLC with EGFR common mutations
Kasuga, Hidefumi
Kataoka, Yuki
Yamamoto, Fuyuki
Mizutani, Takashi
Tsuji, Shingo
Tanaka, Sakiho
Mizuarai, Shinji
CANCER RESEARCH, 2022, 82 (12)
[46] Association of EGFR Exon 19 Deletion and EGFR-TKI treatment duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients
Matsuo, Norikazu
Azuma, Koichi
Sakai, Kazuko
Kawahara, Akihiko
Ishii, Hidenobu
Tokito, Takaaki
Kinoshita, Takashi
Yamada, Kazuhiko
Nishio, Kazuto
Hoshino, Tomoaki
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1201 - S1202
[47] Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC
Wang, Zhijie
Chen, Rui
Wang, Shuhang
Zhong, Jia
Wu, Meina
Zhao, Jun
Duan, Jianchun
Zhuo, Minglei
An, Tongtong
Wang, Yuyan
Bai, Hua
Wang, Jie
PLOS ONE, 2014, 9 (11):
[48] Spectrum of Cancer Types in Kindreds with NSCLC and EGFR T790M Mutations: Results from INHERIT EGFR
Wiesner, Georgia
Ashworth, Renee
Heng, Jennifer C.
Rainville, Irene
Mcreynolds, Katharine
Sable-Hunt, Alicia
Garber, Judy
Carbone, David P.
Oxnard, Geoffrey R.
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S216 - S216
[49] Droplet Digital PCR as a Molecular Tool for the Detection of the EGFR T790M Mutation in NSCLC Patients with the EGFR Activating Mutations
Durgut, S.
Salihefendic, L.
Pecar, D.
Ceko, I
Mulahuseinovic, N.
Izmirlija, M.
Konjhodzic, R.
BALKAN JOURNAL OF MEDICAL GENETICS, 2023, 26 (02) : 21 - 26
[50] Quantitative detection of the T790M EGFR mutation in circulating tumor DNA of lung cancer patients subjected to EGFR-TKI treatment.
Uchida, J.
Taniguchi, K.
Imamura, F.
Nishino, K.
Kumagai, T.
Akazawa, Y.
Okuyama, T.
Kato, K.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

← 1 2 3 4 5 →